Table 1

Characteristics of participants and test results

Background
 Age (year), mean (SD)84.0 (11.1)
 Male, n (%)62 (45.9)
 Inpatient, n (%)19 (14.1)
 Body height, mean (SD)154.0 (11.0)
 Body weight, mean (SD)51.8 (14.7)
 Birthel index, mean (SD)66.2 (36.7)
 Charlson comorbidity index, mean (SD)5.64 (1.82)
Medical history, n (%)
 Heart disease49 (36.8)
 Liver disease11 (8.2)
 Renal disease36 (26.9)
 Lung disease30 (22.2)
 Cancer33 (24.6)
Medication, n (%)
 Calcium channel blocker51 (37.8)
 Beta blocker17 (12.6)
 Diuretic29 (21.5)
 Licorice15 (11.1)
 Non-steroidal anti-inflammatory drugs32 (23.7)
 Pregabalin8 (5.9)
 Limaprost alfadex3 (2.2)
Symptom, n (%)
 Paralysis12 (8.9)
 Snoring4 (3.4)
History of oedema
 Onset, n (%)
 Within 3 days3 (2.2)
 3 days to 3 months63 (46.7)
 Over 3 months48 (35.6)
 Unknown21 (15.6)
 Exacerbation depending on body position or time of day, n (%)37 (30.6)
Physical examination
 Examined while sitting posture, n (%)41 (30.6)
 Skin changes related to lower limb varicose veins, n (%)18 (13.3)
 Thickness of soft tissue in the oedema (mm), mean (SD)10.7 (3.8)
 Pit recovery time (second), mean (SD)105.3 (106.0)
Laboratory variables, mean (SD)
 Hct (%)32.7 (6.9)
 TP (g/dL)6.52 (0.84)
 Albumin (g/dL)3.42 (0.68)
 Na (mEq/L)138.4 (5.1)
 K (mEq/L)4.19 (0.70)
 BUN (mg/dL)24.0 (13.2)
 sCr (mg/dL)1.06 (0.68)
 Glucose (mg/dL)134.4 (52.7)
 CRP (mg/dL)2.77 (4.32)
 BNP (pg/mL)297.2 (511.5)
 BUN (mg/dL)/sCr (mg/dL)25.4 (11.1)
 Estimated Posm (mOsm/L)292.9 (11.3)
Echocardiogram
 IVC diameter (mm), mean (SD)15.4 (5.6)
 Respiratory variation of the IVC, n (%)92 (71.3)
 Estimated TRPG (mm Hg), mean (SD)15.5 (13.9)
 Estimated RVSP (mm Hg), mean (SD)20.9 (16.0)
  • BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CRP, C-reactive protein; Hct, haematocrit; IVC, inferior vena cava; Posm, plasma osmolarity; RVSP, right ventricular systolic pressure; sCr, serum creatinine; TP, total protein; TRPG, transtricuspid pressure gradient.